Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Insight Genetics Promotes Four

Published: Wednesday, February 13, 2013
Last Updated: Wednesday, February 13, 2013
Bookmark and Share
Molecular diagnostics company builds expertise and depth in research, application and commercial development of companion diagnostics to improve cancer care.

Insight Genetics has announced that it has promoted four of its team members:
• Brock Schweitzer, PhD, is now senior scientist;
• Rachel Skelton, PhD, was promoted to regulatory scientist I;
• Kasey Lawrence was named technology specialist; and
• JonEric Pettersson assumed a new role as manager of commercial development.

Since its founding in 2007, Insight Genetics has been dedicated to enabling precision medicine in cancer care. The company collaborates with researchers, clinicians, and drug developers to develop molecular diagnostics that aid physicians in precisely typing and effectively treating patients’ cancers.

“Brock, Rachel, Kasey and JonEric have brought a breadth of knowledge and expertise to Insight Genetics that has helped us consistently generate exceptional scientific results and inform our business development efforts,” said Christopher Callaghan, president and COO of Insight Genetics. “They have all made significant contributions to our company’s growth and been integral in advancing the field of personalized cancer care.”

Senior Scientist Schweitzer, who completed his post-doctoral research training in immune cell function at Vanderbilt University School of Medicine, plans and conducts laboratory research on Insight Genetics’ expanding array of diagnostic tests.

He also contributes to the company’s licensing of biomarkers and technologies, and supports planning and coordination of its academic, clinical and corporate partnerships.

Before joining Insight Genetics as scientist II in 2012, Schweitzer received his PhD in molecular genetics from University of Cincinnati College of Medicine.

As regulatory scientist I, Skelton works with clinicians, researchers and pharmaceutical companies to test patient samples for cancer-causing biomarkers within Insight Genetics’ CLIA-certified molecular diagnostic lab.

She also ensures scientific and regulatory compliance for all tests performed in the lab. Skelton joined Insight Genetics in July 2012 after receiving her PhD in cell and developmental biology from Vanderbilt University School of Medicine, where she became proficient in molecular diagnostics and genetic screening.

As a technology specialist, Lawrence oversees day-to-day operations and conducts research for clinical tests in development, while also managing data in the CLIA lab.

As in his previous role as research associate III, Lawrence will continue to use his research background to apply new techniques and technologies in the company’s diagnostic lab.

Prior to joining Insight Genetics, Lawrence worked as a research assistant at Vanderbilt University’s Division of Genetic Medicine and the Genome Sciences Resource. He holds a bachelor of science in biology from Tennessee Tech University.

Pettersson, as manager of commercial development, guides commercialization of the company’s products for cancer diagnosis and monitoring. He also will identify new diagnostic and partnership opportunities for Insight Genetics.

Pettersson joined Insight Genetics in 2007 and became the company’s senior associate of business development in 2011.

He holds a bachelor’s degree in business administration, with a focus on international business, from Belmont University.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!